
SPIMACO buys 12% more of ENAYAH for SAR 45M, taking its stake to 63%. The deal consolidates control over pharma distribution in Saudi Arabia.
Alpha Score of 59 reflects moderate overall profile with strong momentum, moderate value, moderate quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.
Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) signed a binding agreement to acquire an additional 12% stake in Arabian Medical and Scientific Supplies (ENAYAH) for SAR 45 million. The deal lifts SPIMACO's total ownership in ENAYAH to 63%.
The purchase price values the 12% block at a premium to ENAYAH's recent trading levels. SPIMACO said the transaction aligns with its strategy to consolidate control over distribution channels for pharmaceutical and medical products in Saudi Arabia.
ENAYAH distributes medical equipment, laboratory supplies, and pharmaceutical products across the kingdom. SPIMACO already held a 51% majority stake before this deal. The additional shares come from existing ENAYAH shareholders, the company said in a regulatory filing.
The transaction requires regulatory approvals and is expected to close in the second half of 2025. SPIMACO will fund the purchase from internal cash reserves, according to the filing.
SPIMACO shares traded flat on the Saudi Exchange following the announcement. The stock is down roughly 8% year to date, underperforming the Tadawul All Share Index.
Prepared with AlphaScala editorial tooling from the source reporting linked above. Indexable analysis may include a cited Alpha Score value. Publishing checks screen each story before release. Educational coverage, not personalized advice.